Disease activity following pregnancy-related discontinuation of natalizumab in MS
暂无分享，去创建一个
B. Uitdehaag | M. Wattjes | B. Lissenberg-Witte | J. Killestein | I. Dekker | C. Leurs | I. Kleerekooper | T. Rispens | B. D. de Jong | B. van Oosten | Z. L. van Kempen | C. V. van Munster